Astrazeneca Pharma India Ltd
NSE :ASTRAZEN BSE :506820 Sector : PharmaceuticalsBuy, Sell or Hold ASTRAZEN? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
| 22 Apr 5243.90 (1.04%) | 19 Apr 5189.70 (-0.66%) | 18 Apr 5224.15 (-1.15%) | 16 Apr 5285.10 (1.64%) | 15 Apr 5199.95 (-2.03%) | 12 Apr 5307.70 (-1.68%) | 10 Apr 5398.50 (0.77%) | 09 Apr 5357.25 (-0.60%) | 08 Apr 5389.40 (4.71%) | 05 Apr 5146.75 (1.30%) | 04 Apr 5080.50 (-0.19%) | 03 Apr 5090.00 (-1.19%) | 02 Apr 5151.10 (-0.95%) | 01 Apr 5200.60 (-2.40%) | 28 Mar 5328.45 (0.26%) | 27 Mar 5314.75 (4.57%) | 26 Mar 5082.70 (-0.93%) | 22 Mar 5130.40 (1.97%) | 21 Mar 5031.15 (-0.05%) | 20 Mar 5033.75 (-0.75%) | 19 Mar 5071.60 (-0.50%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Bearish
Long Term Investors
Bullish
Moving Averages
5 DMA
Bullish
5215.15
10 DMA
Bearish
5266.75
20 DMA
Bullish
5204.39
50 DMA
Bearish
5363.4
100 DMA
Bearish
5470.51
200 DMA
Bullish
4881.13
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Apr 22, 2024 04:00 PM For Next Trading Session
| Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
|---|---|---|---|---|---|
| R3 | 5456.14 | 5393.07 | 5281.75 | - | - |
| R2 | 5393.07 | 5340.49 | 5269.14 | 5390.19 | - |
| R1 | 5318.49 | 5308 | 5256.52 | 5312.73 | 5355.78 |
| P | 5255.42 | 5255.42 | 5255.42 | 5252.54 | 5274.06 |
| S1 | 5180.84 | 5202.84 | 5231.28 | 5175.08 | 5218.13 |
| S2 | 5117.77 | 5170.35 | 5218.66 | 5114.89 | - |
| S3 | 5043.19 | 5117.77 | 5206.05 | - | - |
Key Metrics
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Astrazeneca Pharma India Ltd Quaterly Results
| INCOME | |||||
| PROFIT | |||||
| EPS |
Astrazeneca Pharma India Ltd Quaterly Results
| INCOME | 257 | 292.7 | 303.56 | 335.87 | 315.45 |
| PROFIT | 29.3 | 49.12 | 53.86 | 40.71 | 15.8 |
| EPS | 11.72 | 6.91 | 21.54 | 20.95 | 6.32 |
Profit & Loss (Figures in Rs. Crores)
Astrazeneca Pharma India Ltd Profit & Loss
| INCOME | |
| PROFIT | |
| EPS |
Astrazeneca Pharma India Ltd Profit & Loss
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
| INCOME | 517.1 | 516.91 | 565.08 | 540.12 | 634.25 | 745.96 | 884.01 | 823.45 | 805.89 | 1077.93 | |
| PROFIT | -16.93 | -20.84 | 5.22 | 15.77 | 25.9 | 54.41 | 72.03 | 91.72 | 59.55 | 126.25 | |
| EPS | 0 | 0 | 2.1 | 8.02 | 10.36 | 21.78 | 28.88 | 37.32 | 24.64 | 39.72 |
Balance Sheet (Figures in Rs. Crores)
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
| SOURCES OF FUNDS : | ||||||||||
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves Total | 583.69 | 506.39 | 451.17 | 359.44 | 295.8 | 241.93 | 217.87 | 151.01 | 145.76 | 166.6 |
| Total Shareholders Funds | 588.69 | 511.39 | 456.17 | 364.44 | 300.8 | 246.93 | 222.87 | 156.01 | 150.76 | 171.6 |
| Unsecured Loans | 7.21 | 8.63 | 12.14 | 11.84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt | 7.21 | 8.63 | 12.14 | 11.84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 8.56 | 7.5 | 6.41 | 5.38 | 2.02 | 6.66 | 2.28 | 12.92 | 1.02 | 0.49 |
| Total Liabilities | 604.46 | 527.52 | 474.72 | 381.66 | 302.82 | 253.59 | 225.15 | 168.93 | 151.78 | 172.09 |
| APPLICATION OF FUNDS : | ||||||||||
| Gross Block | 179.12 | 168.83 | 159.78 | 132.84 | 119.83 | 105.85 | 102.57 | 203.76 | 191.44 | 169.75 |
| Less : Accumulated Depreciation | 110.26 | 94.34 | 78.82 | 61.31 | 45 | 30.39 | 15.73 | 106.4 | 90.46 | 75.53 |
| Net Block | 68.86 | 74.49 | 80.96 | 71.53 | 74.83 | 75.46 | 86.84 | 97.36 | 100.98 | 94.22 |
| Capital Work in Progress | 1.33 | 2.2 | 4.02 | 24.24 | 6.9 | 3.57 | 4.81 | 6.31 | 12.21 | 9.31 |
| Inventories | 190.21 | 140.22 | 159.8 | 165.15 | 118.1 | 113.15 | 57.71 | 76.73 | 86.13 | 95.76 |
| Sundry Debtors | 107.52 | 85.89 | 85.19 | 83.21 | 79.75 | 54.63 | 43 | 83.14 | 42.77 | 52.93 |
| Cash and Bank Balance | 500.48 | 448.46 | 352.35 | 252.52 | 173.3 | 125.92 | 115.58 | 76.83 | 25.08 | 89.07 |
| Loans and Advances | 37.26 | 31.1 | 21.42 | 41.44 | 33.57 | 27.22 | 35.26 | 30.37 | 109.27 | 36.87 |
| Total Current Assets | 835.47 | 705.67 | 618.76 | 542.32 | 404.72 | 320.92 | 251.55 | 267.07 | 263.26 | 274.62 |
| Current Liabilities | 336.31 | 281.06 | 257.44 | 278.24 | 222.58 | 166.61 | 157.5 | 215.71 | 222.87 | 206.37 |
| Provisions | 44.1 | 47.98 | 42.55 | 46.46 | 36.4 | 40.34 | 32.84 | 18.33 | 36.95 | 37.13 |
| Total Current Liabilities & Provisions | 380.41 | 329.04 | 299.99 | 324.7 | 258.98 | 206.95 | 190.34 | 234.05 | 259.82 | 243.5 |
| Net Current Assets | 455.06 | 376.63 | 318.77 | 217.62 | 145.74 | 113.97 | 61.21 | 33.03 | 3.44 | 31.12 |
| Deferred Tax Assets | 22.2 | 18.17 | 17.31 | 17.47 | 24.42 | 34.32 | 43.56 | 0 | 0 | 0 |
| Deferred Tax Liability | 1.53 | 1.87 | 2.78 | 2.83 | 1.06 | 1.77 | 3.34 | 0 | 0 | 0 |
| Net Deferred Tax | 20.67 | 16.3 | 14.53 | 14.64 | 23.36 | 32.55 | 40.22 | 0 | 0 | 0 |
| Other Assets | 58.54 | 57.9 | 56.44 | 53.63 | 51.99 | 28.04 | 32.07 | 32.24 | 35.14 | 37.43 |
| Total Assets | 604.46 | 527.52 | 474.72 | 381.66 | 302.82 | 253.59 | 225.15 | 168.94 | 151.77 | 172.08 |
| Contingent Liabilities | 130.25 | 121.37 | 85.66 | 67.33 | 26.77 | 7.34 | 15.97 | 16.62 | 12.26 | 14.8 |
Cash Flow (Figures in Rs. Crores)
| Net Profit before Tax and Extr... | 134.1 |
| Depreciation | 16.26 |
| Interest (Net) | -22.49 |
| P/L on Sales of Assets | -2.49 |
| Prov. and W/O (Net) | 1.7 |
| P/L in Forex | -0.15 |
| Total Adjustments (PBT and Ext... | -4.8 |
| Operating Profit before Workin... | 129.3 |
| Trade and 0ther Receivables | -23.17 |
| Inventories | -49.99 |
| Trade Payables | 37.44 |
| Loans and Advances | -0.46 |
| Total Adjustments (OP before W... | -30.19 |
| Cash Generated from/(used in) ... | 99.11 |
| Direct Taxes Paid | -40.82 |
| Total Adjustments(Cash Generat... | -40.82 |
| Cash Flow before Extraordinary... | 58.29 |
| Net Cash from Operating Activi... | 58.29 |
| Purchased of Fixed Assets | -8.52 |
| Sale of Fixed Assets | 3.48 |
| Interest Received | 23.15 |
| Net Cash used in Investing Act... | 18.11 |
| Of Financial Liabilities | -3.85 |
| Dividend Paid | -20 |
| Interest Paid | -0.63 |
| Net Cash used in Financing Act... | -24.48 |
Company Details
Registered Office |
|
| Address | Blk N1 12th Flr Manyata Embass, Rachenahalli Outer Ring Road |
| City | Bangalore |
| State | Karnataka |
| Pin Code | 560045 |
| Tel. No. | 91-080-67748000 |
| Fax. No. | 91-080-67748557 |
| comp.secy@astrazeneca.com | |
| Internet | http://www.astrazeneca.in |
Registrars |
|
| Address | Blk N1 12th Flr Manyata Embass |
| City | Bangalore |
| State | Karnataka |
| Pin Code | 560045 |
| Tel. No. | 91-080-67748000 |
| Fax. No. | 91-080-67748557 |
| comp.secy@astrazeneca.com | |
| Internet | http://www.astrazeneca.in |
Management |
|
| Name | Designation |
| Narayan K Seshadri | Chairman & Independent Directo |
| Revathy Ashok | Non-Exec. & Independent Dir. |
| Rajesh Marwaha. | Whole Time Director & CFO |
| Weiying Sarah Wang | Non Executive Director |
| Ankush Nandra | Non Executive Director |
| Shilpa Divekar Nirula | Non-Exec. & Independent Dir. |
| Sanjeev Panchal | Managing Director |
| Hooi Bien Chuah | Non Executive Director |
